Synthesis and DP-IV inhibition of cyano-pyrazoline derivatives as potent anti-diabetic agents

被引：139

作者：

Ahn, JH ^{[1
]}

Kim, HM ^{[1
]}

Jung, SH ^{[1
]}

Kang, SK ^{[1
]}

Kim, KR ^{[1
]}

Rhee, SD ^{[1
]}

Yang, SD ^{[1
]}

Cheon, HG ^{[1
]}

Kim, SS ^{[1
]}

机构：

[1] Korea Res Inst Chem Technol, Div Med Sci, Taejon 305600, South Korea

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2004年 / 14卷 / 17期

关键词：

dipeptidyl peptidase IV; DP-IV; pyrazoline; anti-diabetic agent;

D O I：

10.1016/j.bmcl.2004.06.046

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A new series of cyano-pyrazoline derivatives with a secondary amine at P-2 site was synthesized through achiral and chiral synthetic methods and evaluated for their ability to inhibit dipeptidyl peptidase IV (DP-IV). Compound 5i revealed good in vivo efficacy (ED50: 4.1 mg/kg; in vivo DP-IV inhibition). Also chiral derivative (11b) having (S)-configuration of compound 5i was found to be more potent. (C) 2004 Elsevier Ltd. All rights reserved.

引用

页码：4461 / 4465

页数：5

共 27 条

[11] DIPEPTIDYLPEPTIDASE-IV HYDROLYZES GASTRIC-INHIBITORY POLYPEPTIDE, GLUCAGON-LIKE PEPTIDE-1(7-36)AMIDE, PEPTIDE HISTIDINE METHIONINE AND IS RESPONSIBLE FOR THEIR DEGRADATION IN HUMAN SERUM [J].

MENTLEIN, R ;

GALLWITZ, B ;

SCHMIDT, WE .

EUROPEAN JOURNAL OF BIOCHEMISTRY, 1993, 214 (03) :829-835

[12] Dipeptidyl-peptidase IV (CD26)-role in the inactivation of regulatory peptides [J].

Mentlein, R .

REGULATORY PEPTIDES, 1999, 85 (01) :9-24

[13] Asymmetric dipolar cycloadditions of Me3SiCHN2. Synthesis of a novel class of amino acids: Azaprolines [J].

Mish, MR ;

Guerra, FM ;

Carreira, EM .

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1997, 119 (35) :8379-8380

[14] Dipeptidyl peptidase IV inhibition improves impaired glucose tolerance in high-fat diet-fed rats: Study using a Fischer 344 rat substrain deficient in its enzyme activity [J].

Mitani, H ;

Takimoto, M ;

Hughes, TE ;

Kimura, M .

JAPANESE JOURNAL OF PHARMACOLOGY, 2002, 88 (04) :442-450

[15] Dipeptidyl peptidase IV inhibitor NVP-DPP728 ameliorates early insulin response and glucose tolerance in aged rats but not in aged Fischer 344 rats lacking its enzyme activity [J].

Mitani, H ;

Takimoto, M ;

Kimura, M .

JAPANESE JOURNAL OF PHARMACOLOGY, 2002, 88 (04) :451-458

[16]

ORSKOV C, 1992, DIABETOLOGIA, V35, P701

[17] 4-Amino cyclohexylglycine analogues as potent dipeptidyl peptidase IV inhibitors [J].

Parmee, ER ;

He, JF ;

Mastracchio, A ;

Edmondson, SD ;

Colwell, L ;

Eiermann, G ;

Feeney, WP ;

Habulihaz, B ;

He, HB ;

Kilburn, R ;

Leiting, B ;

Lyons, K ;

Marsilio, F ;

Patel, RA ;

Petrov, A ;

Di Salvo, J ;

Wu, JK ;

Thornberry, NA ;

Weber, AE .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (01) :43-46

[18] Improved glucose tolerance in rats treated with the dipeptidyl peptidase IV (CD26) inhibitor ile-thiazolidide [J].

Pauly, RP ;

Demuth, HU ;

Rosche, F ;

Schmidt, J ;

White, HA ;

Lynn, F ;

McIntosh, CHS ;

Pederson, RA .

METABOLISM-CLINICAL AND EXPERIMENTAL, 1999, 48 (03) :385-389

[19] Improved glucose tolerance in Zucker fatty rats by oral administration of the dipeptidyl peptidase IV inhibitor isoleucine thiazolidide [J].

Pederson, RA ;

White, HA ;

Schlenzig, D ;

Pauly, RP ;

McIntosh, CHS ;

Demuth, HU .

DIABETES, 1998, 47 (08) :1253-1258

[20] Aminomethylpyrimidines as novel DPP-IV inhibitors:: A 105-fold activity increase by optimization of aromatic substituents [J].

Peters, JU ;

Weber, S ;

Kritter, S ;

Weiss, P ;

Wallier, A ;

Boehringer, M ;

Hennig, M ;

Kuhn, B ;

Loeffler, BM .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (06) :1491-1493

← 1 2 3 →